explore -WSS

explore

author：hotspot 2025-09-29 23:12:20 - browse：956

Allergan, Dom Smith/STAT

It wasn’t supposed to work out this way for Brent Saunders.

Four years ago, Saunders was the whiz kid of the pharmaceutical set. At 44, he had created a large pharmaceutical firm, then called Actavis, almost by force of will after engineering more than $100 billion in deals in a two-year span. Then he had swooped in to rescue Botox maker Allergan from the nefarious claws of Valeant Pharmaceuticals, an asset-stripping drug company loved by many on Wall Street but no one with a conscience.

As CEO, he paired his dealmaking with a boyish charm and a willingness to take on big issues that made him seem like a potential spokesman for the whole industry.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Drug repurposing or repositioning? The language matters
Next article： Drastic changes should bring profitability, startup health insurers say

entertainment

WSS

He's 19 months old and has one of the world’s rarest diseases

$1 billion proposal to grow Boston, Massachusetts biotech

Families look for replacement for GSK asthma drug Flovent

Naloxone nonprofit donates 200,000 doses after FDA approval

Microsoft's Peter Lee: Generative AI could help doctors be more human

IVF doctors demand details after CooperSurgical lawsuit

leisure time

explore

hotspot

In age of alternative facts, a scholarly course on calling out crap

Drastic changes should bring profitability, startup health insurers say

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

NIH trials fail to test meaningful long Covid therapies, experts say

In Memoriam: Notable people who died in 2023

IVF doctors demand details after CooperSurgical lawsuit

Medical leaders decry Supreme Court decision on affirmative action

Wegovy’s successful heart trial raises vital question about weight loss

In age of alternative facts, a scholarly course on calling out crap

Jack Smith previously got search warrant for Trump's Twitter, new court docs show

focus

Emergent cuts jobs, executive role in business shake

Listen: Merck v. USA, the best of ASCO, and Leqembi at the FDA

First over

Medicare drug price negotiation continues, as pharma counteroffers

Biden's 'march

Stem cell biologist probes earliest stages of human development

knowledge

entertainment

hotspot

hotspot